At the last check on Friday, NLS Pharmaceutics AG’s (NASDAQ:NLSP) stock was up $0.13, moving up 18.06 percent to $0.85. The average number of shares traded per day over the past five days has been 328,650 shares. 3 times new highs have been achieved over the past 5 days, with a $0.3175 gain in that time frame. In the last twenty days, the average volume was 1,119,722, while in the previous 50 days, it was 606,459.
Since last month, NLSP stock rose 43.97%. Shares of the company fell to $0.4300 on 11/11/22, the lowest level in the past month. A 52-week high of $2.83 was reached on 01/04/22 after having rallying from a 52-week low of $0.33. Since the beginning of this year, NLSP’s stock price has dropped by -35.14% or -$0.2601, and marked a new high 2 times. However, the stock has declined by -69.96% since its 52-week high.
China Can't Stop US$0.25 Stock from Mining Ultra-Rare Metal
Here's one little-known company — trading undiscovered below 25-cents per share — that's advancing one of the largest and highest quality REE deposits in all of North America... and the Chinese can't do a damn thing about it! It's early stage... and that's excellent news for individual investors like you who have the foresight to act decisively on an emerging megatrend that's already being measured in the Tens of $Billions.
Simply click here and the name & trading symbol are yours.
In the recent quarter, NLS Pharmaceutics AG’s quick ratio stood at 0.60, while its current ratio was 0.60, showing that the company is not able to pay off its debt. Based on annual data, NLSP earned $48000.0 in gross profit and brought in $11.86 million in revenue.
This quick technical analysis looks at NLS Pharmaceutics AG’s (NLSP) price momentum. With a historical volatility rate of 160.49%, the RSI 9-day stood at 74.40% on 23 November.
With respect to its five-day moving average, the current NLS Pharmaceutics AG price is up by +59.64% percent or $0.3175. At present, NLSP shares trade +58.15% above its 20-day simple moving average and +45.28% percent above its 100-day simple moving average. However, the stock is currently trading approximately +0.22% above its SMA50 and -19.82% below its SMA200.
Stochastic coefficient K was 91.53% and Stochastic coefficient D was 75.65%, while ATR was 0.1135. Given the Stochastic reading of 87.48% for the 14-day period, the RSI (14) reading has been calculated as 67.17%. As of today, the MACD Oscillator reading stands at 0.1209, while the 14-day reading stands at 0.1331.
NLS Pharmaceutics AG (NLSP) has been rated Overweight by analysts. According to 0 brokerage firms, NLSP is a sell, and 1 firms recommend it is a Hold. There are 0 analysts who say the stock is underweight. A total of 0 analysts rate NLS Pharmaceutics AG stock as buy, with 2 recommending it as overweight.
With a median target price of $9.75, the current consensus forecast for the stock is $6.00 – $13.50. Based on these forecasts, analysts predict NLS Pharmaceutics AG (NLSP) will achieve an average price target of $9.75.